Novartis May Raise Public Alcon Bid

Novartis AG may raise its $10.4 billion bid for the publicly traded stock of Alcon Inc., the world's largest eye-care company, to appease shareholders who are getting less than the Swiss drugmaker agreed to pay Nestle SA (NSRGY) for its stake.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.